Robin Fuchs, MD
Orthopaedic Surgery · Kirkland, WANPI 1871562595
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Zimmer Biomet at 53.5% of the total. Reporting peaked in 2020 at $946 and has fallen 95.5% since, to $42 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in WA, where the typical reported total is $2,959.
Across 161 payments — averaging $11.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$1K
- DJO, LLC$796
- Convatec Inc.$22
- Stryker$20
- Linvatec Corporation$20
- Heron Therapeutics, Inc.$20
- plus $16 from 1 others
Across 9 payments — averaging $1745.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$16K
What the payments were for
- Speaking & faculty fees$78441%
- Travel & lodging$54628%
- Food & beverage$50326%
- Education$895%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 10 | $1,029 |
| DJO, LLC | 146 | $796 |
| Convatec Inc. | 1 | $22 |
| Stryker | 1 | $20 |
| Linvatec Corporation | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Vericel Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,922 in reported general payments places this provider in the 40th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 78 | $356 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 171 | $292 |
| Ondansetron OdtOndansetron | 48 | $215 |
| Ondansetron Hcl | 25 | $80 |
| Cephalexin | 11 | $65 |
| Meloxicam | 11 | $30 |
| Clindamycin Hcl | 27 | $26 |
| Amoxicillin | 14 | $12 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kirkland
- Adam RothenbergKirkland$111K
- Michael CodsiKirkland$60K
- John PriceKirkland$52K
- William BarrettRenton$7.7M
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.